Prasugrel

Antiplatelet drugs are the cornerstone of treatment for patiens with Acute Coronary Syndromes (ACS) undergoing percutaneous coronary intervention. Clopidogrel and aspirin improve longterm vascular clinical outcomes in these patients and have become a standard of care. However, many patients still ex...

Full description

Bibliographic Details
Main Authors: Gianluca Airoldi, Mauro Campanini
Format: Article
Language:English
Published: PAGEPress Publications 2013-04-01
Series:Italian Journal of Medicine
Subjects:
Online Access:http://www.italjmed.org/index.php/ijm/article/view/232